Ver mas grande
TNFSF11 antibody
FT-FNab09838
Producto nuevo
100 µg
Comprando este producto generará 2 Biopuntos. Su cesta contiene un total 2 Biopuntos puede ser convertido en un Biobonos Descuento 8.00EUR.
Hoja técnica
| Size | 100µg |
| Storage Conditions | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| Applications | ELISA, WB |
| Target | TNFSF11 |
| Research Area | Immunology, Signal Transduction, Developmental biology |
| Form | liquid |
| Recomended Dilution | WB: 1:1000-1:5000 |
| Type Clonality | monoclonal |
| Immunogen | tumor necrosis factor (ligand) superfamily, member 11 |
| Minimum Purity | ≥95% as determined by SDS-PAGE |
| Synonyms | Tumor necrosis factor ligand superfamily member 11|Osteoclast differentiation factor (ODF)|Osteoprotegerin ligand (OPGL)|Receptor activator of nuclear factor kappa-B ligand (RANKL)|TNF-related activation-induced cytokine (TRANCE)|Tumor necrosis factor lig |
| Host | Mouse |
| UniProt ID | O14788 |
| Gene ID | 8600 |
| Purification | Protein A+G purification |
| Clone Number | 4F11 |
| Iso type | IgG1 |
| Reactivity | Human |
| Observed MW | 35 kDa |
| Background | TNFSF11 also known as RANKL, is a member of the tumor necrosis factor (TNF) cytokine family which is a ligand for osteoprotegerin and functions as a key factor for osteoclast differentiation and activation. RANKL induces osteoclast formation through its r |
Más información
RANKL antibody